Novartis AG Sponsored ADR (NVS) - Financials, balance sheet (quarterly)

126.47000 USD

0.42

0.33%

Last update Aug 28, 3:59 PM EDT

Post-market

Day range

126.47000

125.85000

126.88000

Previous close

126.89000

Open

126.36000

Access this stock data via API

Novartis AG Sponsored ADR

126.47

0.42

0.33%

Financials

Balance sheet

Fiscal date	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total assets	104.4B	99.9B	102.2B	103.5B
Current assets	25.9B	25.1B	29.7B	31.3B
Cash	—	—	2.6B	—
Cash equivalents	—	—	8.9B	—
Cash and cash equivalents	6.7B	7.1B	11.5B	13.6B
Other short term investments	344M	130M	1.9B	411M
Accounts receivable	9.1B	8.6B	7.4B	8.0B
Other receivables	—	—	1.4B	—
Inventory	6.3B	5.8B	5.7B	5.9B
Prepaid assets	—	—	985M	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	106M	—
Other current assets	3.5B	3.4B	—	3.2B
Non current assets	78.5B	74.8B	72.5B	72.3B
Properties	11.8B	11.1B	58M	11.2B
Land and improvements	—	—	848M	—
Machinery furniture equipment	—	—	9.2B	—
Construction in progress	—	—	1.6B	—
Leases	—	—	—	—
Accumulated depreciation	—	—	-11.1B	—
Goodwill	80.3B	77.4B	76.4B	77.8B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	29.2B	27.5B	26.9B	27.9B
Investments and advances	2.2B	2.1B	1.1B	2.2B
Other non current assets	9.7B	9.2B	6.2B	6.0B
Total liabilities	62.3B	61.5B	58.1B	60.1B
Current liabilities	31.7B	31.6B	28.7B	28.1B
Accounts payable	4.5B	4.3B	4.6B	4.1B
Accrued expenses	—	—	2.2B	—
Short term debt	8.6B	8.0B	8.3B	6.8B
Deferred revenue	—	—	127M	—
Tax payable	2.8B	2.6B	2.2B	2.2B
Pensions	—	—	2.4B	—
Other current liabilities	15.8B	16.7B	424M	15.1B
Non current liabilities	30.6B	29.9B	29.4B	32.0B
Long term provisions	—	—	561M	—
Long term debt	24.1B	23.2B	22.9B	25.3B
Provision for risks and charges	—	—	—	—
Deferred liabilities	2.3B	2.5B	2.4B	2.2B
Derivative product liabilities	—	—	—	—
Other non current liabilities	4.2B	4.1B	1.0B	4.4B
Shareholders equity
Common stock	766M	766M	793M	793M
Retained earnings	41.5B	39.8B	46.6B	46.3B
Other shareholders equity	-275M	-2.2B	-3.3B	-3.7B
Total shareholders equity	42.1B	38.5B	44.1B	43.4B
Additional paid in capital	—	—	—	—
Treasury stock	33M	19M	53M	40M
Minority interest	69M	83M	80M	124M